Redecan

In August 2026, Redecan’s category mix tilted further toward Pre-Roll at 52.7% share while that category declined 37.4% year over year and 10.9% month over month, and Flower fell harder with a 66.6% year-over-year drop and 9.4% month-over-month dip at 21.9% share. Vapor Pens expanded year over year by 102.7% to 12.7% share but eased 4.2% month over month, while Oil contracted 32.1% year over year and 1.9% month over month at 8.2% share; Capsules decreased 43.6% year over year and 17.2% month over month to 4.6% share. With brand sales down 43.2% year over year and average price up 1.7%, the mix signals that reliance on Pre-Roll and Flower is pressuring overall momentum despite the double‑digit year-over-year lift in Vapor Pens, implying the current portfolio is overweight in declining formats.

The shift toward a still-dominant but shrinking Pre-Roll base and a sharply eroding Flower stake suggests Redecan is ceding volume in its historic core while gaining a smaller but faster-growing foothold in Vapor Pens, a repositioning that redistributes risk but does not yet offset losses. Holding the Pre-Roll rank at 8 in Ontario amid a 37.4% year-over-year category decline and 10.9% month-over-month pullback indicates stable placement but weakening throughput, and the 102.7% year-over-year growth in Vapor Pens coupled with a 4.2% monthly dip points to episodic wins rather than consistent repeat. Given Oil’s 32.1% year-over-year contraction and Capsules’ 17.2% month-over-month slide, the portfolio leans toward price-sensitive, commodity-like segments while premium-adjacent penetration is nascent, implying that near-term defense requires shoring up Pre-Roll efficiency as Vapor Pens scale to a larger share.